hydroxychloroquine has been researched along with Autoimmune Lymphoproliferative Syndrome in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Autoimmune Lymphoproliferative Syndrome: Rare congenital lymphoid disorder due to mutations in certain Fas-Fas ligand pathway genes. Known causes include mutations in FAS, TNFSF6, NRAS, CASP8, and CASP10 proteins. Clinical features include LYMPHADENOPATHY; SPLENOMEGALY; and AUTOIMMUNITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiykim, A | 1 |
| Ogulur, I | 1 |
| Baris, S | 1 |
| Salzer, E | 1 |
| Karakoc-Aydiner, E | 1 |
| Ozen, AO | 1 |
| Garncarz, W | 1 |
| Hirschmugl, T | 1 |
| Krolo, A | 1 |
| Yucelten, AD | 1 |
| Boztug, K | 1 |
| Barlan, IB | 1 |
1 other study available for hydroxychloroquine and Autoimmune Lymphoproliferative Syndrome
| Article | Year |
|---|---|
Potentially Beneficial Effect of Hydroxychloroquine in a Patient with a Novel Mutation in Protein Kinase Cδ Deficiency.
Topics: Antirheumatic Agents; Autoimmune Lymphoproliferative Syndrome; B-Lymphocytes; Child, Preschool; Cyto | 2015 |